PFE vs TSLA: Which Is the Better Buy?
Side-by-side comparison of Pfizer Inc. and Tesla, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-05.
Pfizer Inc. · Healthcare
$26.33
+28.6% upside to fair value
Grade B
VS
Tesla, Inc. · Consumer Cyclical
$387.51
-45.0% upside to fair value
Grade D
QuantHub Verdict
PFE has more upside to fair value
(+28.6%).
PFE trades at a lower forward P/E
(19.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
PFE |
TSLA |
| Current Price |
$26.33 |
$387.51 |
| Fair Value Estimate |
$33.85 |
$213.13 |
| Upside to Fair Value |
+28.6%
|
-45.0%
|
| Market Cap |
$149.8B |
$1,454.1B |
| Forward P/E |
19.3x
|
330.0x
|
| EV / EBITDA |
12.9x
|
122.9x
|
| Price / Sales |
2.4x
|
15.3x
|
| Price / FCF |
16.5x
|
233.8x
|
| Revenue Growth YoY |
-1.2%
|
-3.1%
|
| Gross Margin |
70.3%
|
18.0%
|
| Operating Margin |
24.7%
|
4.6%
|
| Return on Equity |
8.7%
|
4.8%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
6.06%
|
0.43%
|
| Analyst Consensus |
Hold
|
Hold
|
Investment Thesis
Pfizer Inc. is a leading global pharmaceutical company specializing in drug manufacturing with a strong presence in vaccines, oncology, and primary care. The company benefits from a seasoned leadership team under CEO Albert Bourla, who has driven a strategic transformation focusing on science-driven innovation and portfolio optimization. Despite a high gross margin of 70.3% and solid operating ma…
Tesla, Inc. is a leading global manufacturer of electric vehicles, energy storage, and solar products, led by CEO Elon Musk since 2008. The company has a mixed business quality profile with a strong brand and innovation leadership but faces significant challenges including declining automotive revenue, which fell nearly 10% year-over-year in 2025, and a 3.1% revenue decline in the most recent qua…
Accumulation Zones
| Metric |
PFE |
TSLA |
| Zone Low |
$25.39 |
$159.85 |
| Zone High |
$28.77 |
$181.16 |
| In Buy Zone? |
Yes
|
No
|